Cargando…

Stakeholder perspectives on the implementation of genetic carrier screening in a changing landscape

BACKGROUND: In most countries, genetic carrier screening is neither offered, nor embedded in mainstream healthcare. Technological developments have triggered a two-fold transition in carrier screening: the expansion from screening one single disorder to many disorders simultaneously, and offering sc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Holtkamp, Kim C.A., Vos, Evelien M., Rigter, Tessel, Lakeman, Phillis, Henneman, Lidewij, Cornel, Martina C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5314610/ https://www.ncbi.nlm.nih.gov/pubmed/28209157 http://dx.doi.org/10.1186/s12913-017-2083-9

Ejemplares similares

Dynamics of reproductive genetic technologies: Perspectives of professional stakeholders
por: van Dijke, Ivy, et al.
Publicado: (2022)

Factors for successful implementation of population-based expanded carrier screening: learning from existing initiatives
por: Holtkamp, Kim C.A., et al.
Publicado: (2017)

Neonatal and carrier screening for rare diseases: how innovation challenges screening criteria worldwide
por: Cornel, Martina C., et al.
Publicado: (2020)

Direct-to-consumer carrier screening for cystic fibrosis via a hospital website: a 6-year evaluation
por: Holtkamp, Kim C. A., et al.
Publicado: (2018)

Preconceptional genetic carrier testing and the commercial offer directly-to-consumers
por: Borry, Pascal, et al.
Publicado: (2011)

Couples’ experiences with expanded carrier screening: evaluation of a university hospital screening offer
por: van Dijke, Ivy, et al.
Publicado: (2021)

Do people from the Jewish community prefer ancestry-based or pan-ethnic expanded carrier screening?
por: Holtkamp, Kim C A, et al.
Publicado: (2016)

Experiences of a High-Risk Population with Prenatal Hemoglobinopathy Carrier Screening in a Primary Care Setting: a Qualitative Study
por: Holtkamp, Kim C. A., et al.
Publicado: (2017)

Responsible implementation of expanded carrier screening
por: Henneman, Lidewij, et al.
Publicado: (2016)

Attitudes of relatives of mucopolysaccharidosis type III patients toward preconception expanded carrier screening
por: Nijmeijer, Stephanie C. M., et al.
Publicado: (2020)

Preconception expanded carrier screening: Impact of information presented by text or video on genetic knowledge and attitudes
por: Conijn, Thirsa, et al.
Publicado: (2020)

Implementation of Pharmacogenetics in Primary Care: A Multi-Stakeholder Perspective
por: Rigter, Tessel, et al.
Publicado: (2020)

Preconception expanded carrier screening: a focus group study with relatives of mucopolysaccharidosis type III patients and the general population
por: Conijn, Thirsa, et al.
Publicado: (2021)

How will new genetic technologies, such as gene editing, change reproductive decision-making? Views of high-risk couples
por: van Dijke, Ivy, et al.
Publicado: (2020)

Expanding Neonatal Bloodspot Screening: A Multi-Stakeholder Perspective
por: van Dijk, Tessa, et al.
Publicado: (2021)

Views of patients and parents of children with genetic disorders on population‐based expanded carrier screening
por: Woudstra, Anke J., et al.
Publicado: (2022)

Attitudes of general practitioners and midwives towards ethnicity-based haemoglobinopathy-carrier screening
por: Jans, Suze MPJ, et al.
Publicado: (2012)

Reflecting on Earlier Experiences with Unsolicited Findings: Points to Consider for Next-Generation Sequencing and Informed Consent in Diagnostics
por: Rigter, Tessel, et al.
Publicado: (2013)

Moving somatic gene editing to the clinic: routes to market access and reimbursement in Europe
por: Rigter, Tessel, et al.
Publicado: (2021)

Screening for Familial Hypercholesterolemia in Children: What Can We Learn From Adult Screening Programs?
por: Henneman, Lidewij, et al.
Publicado: (2015)

Newborn screening for pompe disease? a qualitative study exploring professional views
por: van El, Carla G, et al.
Publicado: (2014)

Implementing non-invasive prenatal testing for aneuploidy in a national healthcare system: global challenges and national solutions
por: van Schendel, Rachèl V., et al.
Publicado: (2017)

Pursuing Public Health Benefit Within National Genomic Initiatives: Learning From Different Policies
por: Onstwedder, Suzanne M., et al.
Publicado: (2022)

Autosomal recessive disease in children of consanguineous parents: inferences from the proportion of compound heterozygotes
por: ten Kate, Leo P., et al.
Publicado: (2010)

A framework to start the debate on neonatal screening policies in the EU: an Expert Opinion Document
por: Cornel, Martina C, et al.
Publicado: (2014)

With expanded carrier screening, founder populations run the risk of being overlooked
por: Mathijssen, Inge B., et al.
Publicado: (2017)

Genetic educational needs and the role of genetics in primary care: a focus group study with multiple perspectives
por: Houwink, Elisa JF, et al.
Publicado: (2011)

DPD Testing Before Treatment With Fluoropyrimidines in the Amsterdam UMCs: An Evaluation of Current Pharmacogenetic Practice
por: Martens, Forike K., et al.
Publicado: (2020)

Stakeholder Views on Active Cascade Screening for Familial Hypercholesterolemia
por: van El, Carla G., et al.
Publicado: (2018)

Parents’ Perspectives and Societal Acceptance of Implementation of Newborn Screening for SCID in the Netherlands
por: Blom, Maartje, et al.
Publicado: (2020)

Lay perceptions of predictive testing for diabetes based on DNA test results versus family history assessment: a focus group study
por: Wijdenes-Pijl, Miranda, et al.
Publicado: (2011)

Challenges in the care for consanguineous couples: an exploratory interview study among general practitioners and midwives
por: Teeuw, Marieke E, et al.
Publicado: (2012)

Societal implications of expanded universal carrier screening: a scoping review
por: van den Heuvel, Lieke M., et al.
Publicado: (2022)

Implementation of Electronic Informed Consent in Biomedical Research and Stakeholders’ Perspectives: Systematic Review
por: De Sutter, Evelien, et al.
Publicado: (2020)

Using web-based familial risk information for diabetes prevention: a randomized controlled trial
por: Wijdenes, Miranda, et al.
Publicado: (2013)

Informed consent for exome sequencing in diagnostics: exploring first experiences and views of professionals and patients
por: Rigter, T, et al.
Publicado: (2014)

Expanded Neonatal Bloodspot Screening Programmes: An Evaluation Framework to Discuss New Conditions With Stakeholders
por: Jansen, Marleen E., et al.
Publicado: (2021)

Public support for neonatal screening for Pompe disease, a broad-phenotype condition
por: Weinreich, Stephanie Shifra, et al.
Publicado: (2012)

Consanguineous marriage and reproductive risk: attitudes and understanding of ethnic groups practising consanguinity in Western society
por: Teeuw, Marieke E, et al.
Publicado: (2014)

Envisioning Implementation of a Personalized Approach in Breast Cancer Screening Programs: Stakeholder Perspectives
por: Esquivel-Sada, Daphne, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_k4gnfj0pj8vpj2aoah19m90ara